273 related articles for article (PubMed ID: 20699413)
1. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
3. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
4. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Mafuvadze B; Benakanakere I; López Pérez FR; Besch-Williford C; Ellersieck MR; Hyder SM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1316-24. PubMed ID: 21505181
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
6. Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats.
Rajakumar T; Pugalendhi P; Thilagavathi S
Chem Biol Interact; 2015 Apr; 231():35-43. PubMed ID: 25744308
[TBL] [Abstract][Full Text] [Related]
7. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Endocr Relat Cancer; 2009 Mar; 16(1):85-98. PubMed ID: 19075036
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive potential of genistein and daidzein in combination during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats.
Pugalendhi P; Manoharan S
Pak J Biol Sci; 2010 Mar; 13(6):279-86. PubMed ID: 20506715
[TBL] [Abstract][Full Text] [Related]
11. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
12. Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin.
Wiehle RD; Christov K; Mehta R
Oncol Rep; 2007 Jul; 18(1):167-74. PubMed ID: 17549364
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
[TBL] [Abstract][Full Text] [Related]
14. Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis.
De Jonage-Canonico MB; Lenoir V; Martin A; Scholler R; Kerdelhué B
Breast Cancer Res Treat; 2003 Jun; 79(3):365-77. PubMed ID: 12846421
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene.
Barros AC; Muranaka EN; Mori LJ; Pelizon CH; Iriya K; Giocondo G; Pinotti JA
Rev Hosp Clin Fac Med Sao Paulo; 2004 Oct; 59(5):257-61. PubMed ID: 15543396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
18. Combined supplementation of vanadium and fish oil suppresses tumor growth, cell proliferation and induces apoptosis in DMBA-induced rat mammary carcinogenesis.
Manna S; Das S; Chatterjee M; Janarthan M; Chatterjee M
J Cell Biochem; 2011 Sep; 112(9):2327-39. PubMed ID: 21503968
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
20. Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
Labrie F; Li S; Bélanger A; Côté J; Mérand Y; Lepage M
Breast Cancer Res Treat; 1993; 26(3):253-65. PubMed ID: 8251650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]